Novaliq Submits New Drug Application Seeking Approval For Firs...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
HEIDELBERG, Germany, and CAMBRIDGE, MA, August 9, 2022, /PRNewswire-AsiaNet/-- Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol(R) water-free technology, today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administrat...
Authors: LATEST ASIANET NEWS RELEASES